Effect of Tirzepatide on Health-Related Quality of Life in Japanese Patients With Obesity Disease: Patient-Reported Outcomes From the SURMOUNT-J Study.

Diabetes Obes Metab · 2026 · PMC13341361 · PMID 42108080

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The benefit of tirzepatide was lower and did not reach statistical significance for any IWQOL‐Lite‐CT scores in the ≥ 65 years subgroup, which had a small sample size and higher variability than the < 65 years subgroup.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.